{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:51:12Z","timestamp":1791348672929,"version":"4.3.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pt.2026.09.013","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:03:12Z","timestamp":1790121792000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["LARC-GAPs: emerging whole-sporozoite vaccines for high-level sterile protection against malaria"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7083-0651","authenticated-orcid":false,"given":"Plabita","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8879-3030","authenticated-orcid":false,"given":"Indrani","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6929-766X","authenticated-orcid":false,"given":"Raksha","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-6416","authenticated-orcid":false,"given":"Satish","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2026.09.013_bb0005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/d41586-026-01253-w","volume":"652","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.09.013_bb0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2026.09.013_bb0015","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0140-6736(26)00248-5","article-title":"Impact of introducing RTS,S\/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme","volume":"407","author":"Mwapasa","year":"2026","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pt.2026.09.013_bb0020","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1016\/j.vaccine.2011.07.081","article-title":"Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites","volume":"29","author":"Mishra","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2026.09.013_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s44321-024-00057-7","article-title":"A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion","volume":"16","author":"Goswami","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41541-024-00975-0","article-title":"A Plasmodium late liver stage arresting GAP provides superior protection in mice","volume":"9","author":"Mishra","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2026.09.013_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-025-01149-2","article-title":"A Plasmodium LARC GAP provides preerythrocytic, stage and species transcending protection in mice","volume":"10","author":"Devi","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2026.09.013_bb0040","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1038\/s44321-024-00131-0","article-title":"Whole-sporozoite malaria vaccines: where we are, where we are going","volume":"16","author":"Moita","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.977472","article-title":"Five decades of clinical assessment of whole-sporozoite malaria vaccines","volume":"13","author":"Nunes-Caba\u00e7o","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2026.09.013_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41541-025-01265-z","article-title":"The path from early- to late-liver stage arresting genetically attenuated parasites as a malaria vaccination strategy","volume":"10","author":"Lamers","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2026.09.013_bb0055","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.09.013_bb0060","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2026.09.013_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria","volume":"6","author":"Hoffman","year":"2010","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.pt.2026.09.013_bb0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.09.013_bb0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.09.013_bb0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-021-03684-z","article-title":"Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity","volume":"595","author":"Mwakingwe-Omari","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.09.013_bb0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature03188","article-title":"Genetically modified Plasmodium parasites as a protective experimental malaria vaccine","volume":"433","author":"Mueller","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.09.013_bb0090","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1242\/jeb.00644","article-title":"Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine","volume":"206","author":"Luke","year":"2003","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.pt.2026.09.013_bb0095","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/14760584.2023.2245890","article-title":"Sporozoite immunization: innovative translational science to support the fight against malaria","volume":"22","author":"Richie","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.pt.2026.09.013_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1473-3099(21)00332-7","article-title":"Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial","volume":"22","author":"Sissoko","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.09.013_bb0105","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S1473-3099(24)00360-8","article-title":"Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1, and 2 trials","volume":"24","author":"Diawara","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.09.013_bb0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordm\u00fcller","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.09.013_bb0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41591-025-04107-6","article-title":"Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial","volume":"32","author":"Kapulu","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0120","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","article-title":"Protection against a malaria challenge by sporozoite inoculation","volume":"361","author":"Roestenberg","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0125","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1016\/j.vaccine.2023.11.023","article-title":"Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines","volume":"41","author":"Moita","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2026.09.013_bb0130","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/mmi.15246","article-title":"Stearoyl-CoA desaturase regulates organelle biogenesis and hepatic merozoite formation in Plasmodium berghei","volume":"121","author":"Narwal","year":"2024","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2026.09.013_bb0135","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acsinfecdis.4c00362","article-title":"A micronemal protein, Scot1, is essential for apicoplast biogenesis and liver stage development in Plasmodium berghei","volume":"10","author":"Ghosh","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.pt.2026.09.013_bb0140","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/330664a0","article-title":"\u03b3 Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites","volume":"330","author":"Schofield","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.09.013_bb0145","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection","volume":"45","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.pt.2026.09.013_bb0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41541-022-00510-z","article-title":"A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection","volume":"7","author":"Mordm\u00fcller","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2026.09.013_bb0155","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41467-021-22740-w","article-title":"Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial","volume":"12","author":"Sulyok","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.09.013_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127009","article-title":"Meeting report: expert consultation on late arresting replication competent (LARC) malaria sporozoite vaccine research & development","volume":"54","author":"Mo","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2026.09.013_bb0165","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013390","article-title":"Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination","volume":"13","author":"M\u00fcller","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.85.2.573","article-title":"CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.09.013_bb0175","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.2524877","article-title":"Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes","volume":"244","author":"Hoffman","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.09.013_bb0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.171.3.763","article-title":"Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes","volume":"171","author":"Weiss","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0185","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm1628","article-title":"CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes","volume":"13","author":"Chakravarty","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.chom.2011.05.008","article-title":"Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites","volume":"9","author":"Butler","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2026.09.013_bb0195","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/IAI.01417-15","article-title":"A Plasmodium yoelii Mei2-like RNA binding protein is essential for completion of liver stage schizogony","volume":"84","author":"Dankwa","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2026.09.013_bb0200","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s42003-024-07063-y","article-title":"A conserved Plasmodium nuclear protein is critical for late liver stage development","volume":"7","author":"Goswami","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.pt.2026.09.013_bb0205","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1073\/pnas.0408442102","article-title":"Plasmodium liver stage developmental arrest by depletion of a protein at the parasite\u2013host interface","volume":"102","author":"Mueller","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.09.013_bb0210","doi-asserted-by":"crossref","first-page":"12194","DOI":"10.1073\/pnas.0500925102","article-title":"Genetically attenuated P36p-deficient malarial sporozouites induce protective immunity and apoptosis of infected liver cells","volume":"102","author":"van Dijk","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.09.013_bb0215","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1086\/519742","article-title":"Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells","volume":"196","author":"Tarun","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2026.09.013_bb0220","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/519743","article-title":"Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells","volume":"196","author":"Jobe","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2026.09.013_bb0225","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/IAI.00225-07","article-title":"Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection","volume":"75","author":"Labaied","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2026.09.013_bb0230","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.vaccine.2012.02.010","article-title":"Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates","volume":"30","author":"Annoura","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2026.09.013_bb0235","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.vaccine.2013.08.007","article-title":"First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers","volume":"31","author":"Spring","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2026.09.013_bb0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2958.2008.06271.x","article-title":"Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection","volume":"69","author":"Aly","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2026.09.013_bb0245","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.chom.2008.11.001","article-title":"The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites","volume":"4","author":"Yu","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2026.09.013_bb0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/mmi.12083","article-title":"Liver-specific protein 2: a Plasmodium protein exported to the hepatocyte cytoplasm and required for merozoite formation","volume":"87","author":"Orito","year":"2013","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2026.09.013_bb0255","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03582","article-title":"A genetically attenuated malaria vaccine candidate based on P. falciparum b9\/slarp gene-deficient sporozoites","volume":"3","author":"van Schaijk","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.pt.2026.09.013_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5629","article-title":"A double-blind, placebo-controlled phase 1\/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1","volume":"12","author":"Roestenberg","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0265","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","article-title":"Safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite","volume":"391","author":"Lamers","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/srep40407","article-title":"A novel and conserved Plasmodium sporozoite membrane protein SPELD is required for maturation of exo-erythrocytic forms","volume":"7","author":"Al-Nihmi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2026.09.013_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aad9099","article-title":"Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects","volume":"9","author":"Kublin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn9709","article-title":"A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection","volume":"14","author":"Murphy","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41541-022-00558-x","article-title":"Creation and preclinical evaluation of genetically attenuated malaria parasites arresting growth late in the liver","volume":"7","author":"Franke-Fayard","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2026.09.013_bb0290","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-024-03347-2","article-title":"Single immunization with genetically attenuated Pf\u2206mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial","volume":"31","author":"Roozen","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.09.013_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003549","article-title":"Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes","volume":"3","author":"van Schaijk","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2026.09.013_bb0300","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1096\/fj.13-241570","article-title":"Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development","volume":"28","author":"Annoura","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.pt.2026.09.013_bb0305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2353\/ajpath.2007.060792","article-title":"Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells","volume":"171","author":"Mueller","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pt.2026.09.013_bb0310","doi-asserted-by":"crossref","first-page":"13004","DOI":"10.1073\/pnas.0906387106","article-title":"Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design","volume":"106","author":"VanBuskirk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.09.013_bb0315","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/mt.2014.85","article-title":"A next-generation genetically attenuated Plasmodium falciparum parasite created by triple gene deletion","volume":"22","author":"Mikolajczak","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pt.2026.09.013_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.00088-18","article-title":"A Plasmodium parasite with complete late liver stage arrest protects against preerythrocytic and erythrocytic stage infection in mice","volume":"86","author":"Vaughan","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2026.09.013_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.135589","article-title":"A replication-competent late liver stage\u2013attenuated human malaria parasite","volume":"5","author":"Goswami","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.pt.2026.09.013_bb0330","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1462-5822.2009.01333.x","article-title":"LISP1 is important for the egress of Plasmodium berghei parasites from liver cells","volume":"11","author":"Ishino","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.pt.2026.09.013_bb0335","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","article-title":"Type II fatty acid synthesis is essential only for malaria parasite late liver stage development","volume":"11","author":"Vaughan","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.pt.2026.09.013_bb0340","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/EC.00264-13","article-title":"Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes","volume":"13","author":"van Schaijk","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.pt.2026.09.013_bb0345","first-page":"1","article-title":"Protective efficacy and safety of liver stage attenuated malaria parasites","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2026.09.013_bb0350","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41541-023-00778-9","article-title":"The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria","volume":"8","author":"Moita","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2026.09.013_bb0355","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41590-018-0228-6","article-title":"Malaria prevention: from immunological concepts to effective vaccines and protective antibodies","volume":"19","author":"Cockburn","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pt.2026.09.013_bb0360","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.pt.2025.10.007","article-title":"Exposing the hidden: establishing immunity to Plasmodium liver stage infection","volume":"41","author":"Quin","year":"2025","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.09.013_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009594","article-title":"PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: a randomized, placebo-controlled trial with controlled human malaria infection","volume":"17","author":"Murphy","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.09.013_bb0370","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/infdis\/jiu293","article-title":"Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites","volume":"210","author":"Bijker","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2026.09.013_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112589","article-title":"Correlative humoral and cellular immunity to genetically attenuated malaria parasites in humans","volume":"28","author":"Colstrup","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.pt.2026.09.013_bb0380","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.celrep.2018.08.094","article-title":"CD8+ T cell activation leads to constitutive formation of liver tissue-resident memory t cells that seed a large and flexible niche in the liver","volume":"25","author":"Holz","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.pt.2026.09.013_bb0385","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41590-025-02397-z","article-title":"\u03b3\u03b4 T cell-derived IL-4 initiates CD8(+) T cell immunity","volume":"27","author":"Le","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pt.2026.09.013_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.02194-18","article-title":"Antibody-mediated protection against plasmodium sporozoites begins at the dermal inoculation site","volume":"9","author":"Flores-Garcia","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.pt.2026.09.013_bb0395","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00218-21","article-title":"Clustering and erratic movement patterns of syringe-injected versus mosquito-inoculated malaria sporozoites underlie decreased infectivity","volume":"6","author":"de Korne","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.pt.2026.09.013_bb0400","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1038\/s41598-024-53118-9","article-title":"Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria","volume":"14","author":"Watson","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2026.09.013_bb0405","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41586-022-05466-7","article-title":"In vitro production of infectious Plasmodium falciparum sporozoites","volume":"612","author":"Eappen","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.pt.2026.09.013_bb0410","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41467-022-30882-8","article-title":"Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ vaccine in Africa","volume":"13","author":"Silva","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226002849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226002849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:27:13Z","timestamp":1791347233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492226002849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":82,"alternative-id":["S1471492226002849"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2026.09.013","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LARC-GAPs: emerging whole-sporozoite vaccines for high-level sterile protection against malaria","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2026.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}